The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 8,745,854 | 65,630 | SH | SOLE | 65,630 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 2,092,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| AN2 THERAPEUTICS INC | COM | 037326105 | 193,600 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | 6,895,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | 242,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 5,995,873 | 324,452 | SH | SOLE | 324,452 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 2,661,900 | 570,000 | SH | SOLE | 570,000 | 0 | 0 | ||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 33,068 | 59,700 | SH | SOLE | 59,700 | 0 | 0 | ||
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 243,880 | 26,000 | SH | SOLE | 26,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | 450,000 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| EDESA BIOTECH INC | COM NEW | 27966L306 | 6,727,575 | 827,500 | SH | SOLE | 827,500 | 0 | 0 | ||
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | 2,326,720 | 352,000 | SH | SOLE | 352,000 | 0 | 0 | ||
| EVOMMUNE INC | COM SHS | 30054Y107 | 5,930,729 | 446,255 | SH | OTR | 0 | 446,255 | 0 | ||
| EVOMMUNE INC | COM SHS | 30054Y107 | 66,450 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 11,522 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 3,735,904 | 8,753,290 | SH | SOLE | 8,753,290 | 0 | 0 | ||
| IMMIX BIOPHARMA INC | COM | 45258H106 | 11,186,350 | 1,085,000 | SH | SOLE | 1,085,000 | 0 | 0 | ||
| IMMUNOME INC | COM | 45257U108 | 211,900 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| INSPIREMD INC | COM | 45779A846 | 103,711 | 148,138 | SH | SOLE | 148,138 | 0 | 0 | ||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 1,020,111 | 2,423,067 | SH | SOLE | 2,423,067 | 0 | 0 | ||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 103,283 | 245,328 | SH | OTR | 0 | 245,328 | 0 | ||
| KALARIS THERAPEUTICS INC | COM | 482929106 | 101,750 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | 195,400 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 100,650 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
| LYELL IMMUNOPHARMA INC | COM NEW | 55083R203 | 1,475,250 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 277,200 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | 17,665,285 | 492,893 | SH | OTR | 0 | 492,893 | 0 | ||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | 296,780 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | ||
| NASUS PHARMA LTD | ORD SHS | M7071P109 | 1,257,865 | 359,390 | SH | SOLE | 359,390 | 0 | 0 | ||
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | 391,000 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 388,160 | 16,000 | SH | SOLE | 16,000 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 349,700 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 29,722,991 | 88,781 | SH | SOLE | 88,781 | 0 | 0 | ||
| PRECISION BIOSCIENCES INC | COM NEW | 74019P207 | 314,400 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| PROFOUND MED CORP | COM NEW | 74319B502 | 1,132,349 | 170,278 | SH | SOLE | 170,278 | 0 | 0 | ||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 83,700 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 453,546 | 3,700 | SH | SOLE | 3,700 | 0 | 0 | ||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 10,866,571 | 2,844,652 | SH | SOLE | 2,844,652 | 0 | 0 | ||
| QUOIN PHARMACEUTICALS LTD | SPONSORED ADS | 74907L409 | 156,680 | 32,372 | SH | SOLE | 32,372 | 0 | 0 | ||
| REIN THERAPEUTICS INC | COM NEW | 00887A204 | 1,768,000 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
| REPLIMUNE GROUP INC | COM | 76029N106 | 221,400 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 3,900,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 205,200 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292309 | 162,800 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | 17,003,712 | 512,160 | SH | SOLE | 512,160 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 218,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| TECTONIC THERAPEUTIC INC | COM | 878972108 | 206,250 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | 8,002,282 | 549,985 | SH | SOLE | 549,985 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | 999,585 | 68,700 | SH | Call | SOLE | 68,700 | 0 | 0 | |
| VERRICA PHARMACEUTICALS INC | COM SHS | 92511W207 | 2,885,941 | 471,559 | SH | SOLE | 471,559 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 183,700 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 4,105,500 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
| XILIO THERAPEUTICS INC | COM | 98422T209 | 136,850 | 14,285 | SH | SOLE | 14,285 | 0 | 0 | ||